FrancophonIA/ELRC3.0 huggingface dataset:
English: Annex IV Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Slovenian: Priloga IV Znanstveni zaključki in podlaga za spremembo pogojev dovoljenja (dovoljenj) za promet z zdravilom
English: It helps your body reduce your blood sugar level only when blood sugar is too high.
Slovenian: Zdravilo pomaga telesu zmanjšati koncentracijo krvnega sladkorja, le kadar je krvni sladkor previsok.
English: If you selected a wrong dose by mistake, simply change it by turning the dose selector backwards or forwards until the right dose lines up with the pointer.
Slovenian: Če ste pomotoma izbrali napačen odmerek, ga preprosto spremenite tako, da izbirnik odmerka zavrtite naprej ali nazaj, dokler ni s kazalnikom poravnan želeni odmerek.
English: A stepwise approach to insulin dose reduction is recommended.
Slovenian: Priporoča se postopen pristop k zmanjševanju odmerka insulina.
English: Keep the dose button pressed down and leave the needle under the skin for at least 6 seconds.
Slovenian: Še naprej držite potisni gumb, igla pa naj pod kožo ostane vsaj 6 sekund.
English: Two minor plasma metabolites were detected (≤9% and ≤5% of total plasma radioactivity exposure).
Slovenian: Odkrili so tudi dva manj pomembna presnovka v plazmi (≤9 % in ≤5 % celotne plazemske izpostavljenosti radioaktivnosti).
English: There is no therapeutic experience in patients with congestive heart failure New York Heart Association (NYHA) class IV, and liraglutide is therefore not recommended for use in these patients.
Slovenian: Izkušenj pri zdravljenju bolnikov s srčnim popuščanjem razreda IV po razvrstitvi New York Heart Association (NYHA) ni in zato uporaba liraglutida pri teh bolnikih ni priporočljiva.
English: It is important to avoid dehydration by drinking plenty of fluids.
Slovenian: Pomembno je preprečiti dehidracijo, tako da pijete veliko tekočin.
English: Victoza must not be administered intravenously or intramuscularly.
Slovenian: Zdravila Victoza se ne sme aplicirati intravensko ali intramuskularno.
English: Split your dose into two injections:
Slovenian: V tem primeru lahko: Odmerek razdelite na dve injiciranji:
English: • Beta-cell function
Slovenian: • Delovanje celic beta
English: These findings in rodents are caused by a non-genotoxic, specific GLP-1 receptor-mediated mechanism to which rodents are particularly sensitive.
Slovenian: Te učinke pri glodalcih povzroča negenotoksičen, specifičen mehanizem prek receptorjev GLP-1, za katerega so glodalci zelo občutljivi.
English: Combination with oral antidiabetics
Slovenian: Kombinacija s peroralnimi antidiabetiki
English: Pharmacokinetic properties were assessed in clinical studies in the paediatric population with type 2 diabetes aged 10 years and above.
Slovenian: Farmakokinetične lastnosti so ocenili v kliničnih študijah znotraj pediatrične populacije s sladkorno boleznijo tipa 2 v starosti 10 let ali več.
English: • If you are using insulin, your doctor will tell you how to reduce the dose of insulin and will recommend you to monitor your blood sugar more frequently, in order to avoid hyperglycaemia (high blood sugar) and diabetic ketoacidosis (a complication of diabetes that occurs when the body is unable to break down glucose because there is not enough insulin).
Slovenian: • če uporabljate insulin; zdravnik vam bo povedal, kako zmanjšate odmerek insulina, ter vam priporočil pogostejše spremljanje sladkorja v krvi, da preprečite pojav hiperglikemije (visoka raven sladkorja v krvi) in diabetične ketoacidoze (zaplet pri sladkorni bolezni, ki nastopi, ko telo zaradi pomanjkanja insulina ni sposobno razgraditi glukoze).
English: MACE: major adverse cardiovascular event %: proportion in percent of subjects with an event N: number of subjects
Slovenian: MACE: pomembni srčno-žilni neželeni dogodki %: delež preiskovancev, ki so doživeli dogodek, v odstotkih N: število preiskovancev
English: Keep away from the freezer compartment.
Slovenian: Ne shranjujte v bližini zamrzovalnega razdelka.
English: • Blood pressure and heart rate
Slovenian: • Krvni tlak in srčni utrip
English: Both treatments resulted in mean body weight loss of approximately 3 kg.
Slovenian: Pri obeh zdravljenjih se je telesna masa v povprečju zmanjšala za približno 3 kg.
English: This is because it may block the injection.
Slovenian: S tem namreč lahko ustavite injiciranje.
English: Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila: http://www.ema.europa.eu/.
English: • A severe form of allergic reaction (anaphylactic reaction) with additional symptoms such as breathing problems, swelling of throat and face, fast heartbeat, etc.
Slovenian: • huda oblika alergijske reakcije (anafilaktična reakcija) z dodatnimi simptomi, kot so težave z dihanjem, otekanje grla in obraza, hiter utrip srca, itd.
English: • Clean the pen with a cloth moistened with a mild detergent.
Slovenian: • Čistite ga s krpo, navlaženo z blagim detergentom.
English: From clinical trials and marketed use, overdoses have been reported of up to 40 times (72 mg) the recommended maintenance dose.
Slovenian: V kliničnih študijah in po prihodu zdravila na trg so poročali o prevelikih odmerjanjih zdravila, vse do 40-kratnega (72 mg) največjega priporočenega vzdrževalnega odmerka.
English: Primary outcome or vital status at end of trial was available for 99.7% and 99.6% of participants randomised to liraglutide and placebo, respectively.
Slovenian: Primarni izid oz. vitalni status na koncu preskušanja je bil na voljo za 99,7 % preiskovancev, ki so prejemali liraglutid in 99,6 % preiskovancev, ki so prejemali placebo.
English: Victoza is given as an injection under the skin (subcutaneous).
Slovenian: Zdravilo Victoza je namenjeno injiciranju pod kožo (subkutana uporaba).
English: Patients should be advised to take precautions to avoid hypoglycaemia while driving and using machines, in particular when Victoza is used in combination with a sulfonylurea or insulin.
Slovenian: Bolnikom je treba svetovati, naj upoštevajo previdnostne ukrepe in se tako izognejo hipoglikemiji med vožnjo in upravljanjem strojev, predvsem kadar uporabljajo zdravilo Victoza skupaj s sulfonilsečnino ali insulinom.
English: Liraglutide is metabolised in a similar manner to large proteins without a specific organ having been identified as major route of elimination.
Slovenian: Presnova liraglutida je podobna presnovi velikih beljakovin in ni nobenega določenega organa, ki bi veljal kot glavna pot izločanja.
English: Do not use this medicine if the solution is not clear and colourless or almost colourless.
Slovenian: Tega zdravila ne uporabljajte, če raztopina ni bistra in brezbarvna ali skoraj brezbarvna.
English: Pharmacotherapeutic group: Drugs used in diabetes, glucagon-like peptide-1 (GLP-1) analogues.
Slovenian: Farmakoterapevtska skupina: Zdravila za zdravljenje diabetesa, analogi glukagonu podobnega peptida-1 (GLP-1).
English: Weight loss was sustained.
Slovenian: Izguba telesne mase se je ohranila.
English: The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed Risk Management Plan (RMP) presented in Module 1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the RMP.
Slovenian: Imetnik dovoljenja za promet z zdravilom bo izvedel zahtevane farmakovigilančne aktivnosti in ukrepe, podrobno opisane v sprejetem RMP, predloženem v modulu 1.8.2 dovoljenja za promet z zdravilom, in vseh nadaljnjih posodobitvah RMP.
English: Important information about some of the ingredients of Victoza
Slovenian: Pomembne informacije o nekaterih sestavinah zdravila Victoza
English: During 24 hours following administration of a single radiolabelled [3H]-liraglutide dose to healthy subjects, the major component in plasma was intact liraglutide.
Slovenian: V 24 urah po aplikaciji enega odmerka radioaktivno označenega [3H]-liraglutida zdravim osebam je bila glavna komponenta v plazmi nespremenjen liraglutid.
English: A large cardiovascular outcomes trial (the LEADER trial) was also conducted with liraglutide in 9,340 patients with type 2 diabetes mellitus at high cardiovascular risk.
Slovenian: Obsežno preskušanje o srčno-žilnih izidih (preskušanje LEADER) je bilo prav tako izvedeno z liraglutidom pri 9.340 bolnikih s sladkorno boleznijo tipa 2 in velikim tveganjem za srčno-žilne dogodke.
English: Daily doses higher than 1.8 mg are not recommended.
Slovenian: Ne priporočamo dnevnih odmerkov, ki so večji od 1,8 mg.
English: The Liraglutide Effect and Action in Diabetes Evaluation of Cardiovascular Outcome Results (LEADER) trial, was a multicentre, placebo-controlled, double-blind clinical trial.
Slovenian: Preskušanje LEADER (Liraglutide Effect and Action in Diabetes Evaluation of Cardiovascular Outcome Results) je bilo multicentrično, s placebom nadzorovano, dvojno slepo klinično preskušanje.
English: The liraglutide exposure in adolescents and children was comparable to that observed in the adult population.
Slovenian: Izpostavljenost liraglutidu je bila pri mladostnikih in otrocih primerljiva tisti, ki so jo opažali v odrasli populaciji.
English: Pancreatitis (including necrotising pancreatitis)
Slovenian: (vključno z nekrotizirajočim pankreatitisom)
English: Liraglutide did not reduce the plaque size of already established plaques.
Slovenian: Liraglutid ni zmanjšal velikosti že nastalega plaka.
English: Liraglutide is a GLP-1 analogue with 97% sequence homology to human GLP-1 that binds to and activates the GLP-1 receptor.
Slovenian: Liraglutid je analog glukagonu podobnega peptida-1 (GLP-1) s 97 % sekvenčno homologijo s človeškim GLP-1, ki se veže na receptor za GLP-1 (GLP-1R) in ga aktivira.
English: Then follow the instructions below:
Slovenian: Nato sledite spodnjim navodilom.
English: Please consult your doctor for further information on this topic.
Slovenian: Za več informacij se posvetujte z zdravnikom.
English: In animal studies, peripheral administration of liraglutide led to uptake in specific brain regions involved in regulation of appetite, where liraglutide via specific activation of the GLP-1 receptor (GLP-1R) increased key satiety and decreased key hunger signals, thereby leading to lower body weight.
Slovenian: V študijah na živalih je liraglutid po perifernem odmerjanju prešel v dele možganov, ki so vključeni v uravnavanje apetita, kjer je liraglutid prek specifične aktivacije GLP-1R zvišal ključne signale za sitost in zmanjšal ključne signale za lakoto, kar je posledično vodilo v zmanjšanje telesne mase.
English: EXP Discard pen 1 month after first use.
Slovenian: EXP: Injekcijski peresnik zavrzite 1 mesec po prvi uporabi.
English: Then prepare a new pen for injection and inject the remaining number of mg to complete your dose.
Slovenian: Nato pripravite nov peresnik za injiciranje in injicirajte preostalo število mg do celotnega odmerka.
English: Victoza is indicated for the treatment of adults, adolescents and children aged 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
Slovenian: Zdravilo Victoza je namenjeno zdravljenju odraslih, mladostnikov in otrok, starih 10 let ali več, z neustrezno nadzorovano sladkorno boleznijo tipa 2 kot dodatek k dieti in telesni vadbi:
English: Most episodes of confirmed hypoglycaemia in clinical trials were minor.
Slovenian: Večina potrjenih hipoglikemij v kliničnih preskušanjih je bila blagih.
English: Increase in insulin glargine dose (IU)
Slovenian: Povečanje odmerka insulina glargin (i.e.)
English: The apparent volume of distribution after subcutaneous administration is 11-17 l. The mean volume of distribution after intravenous administration of liraglutide is 0.07 l/kg.
Slovenian: Navidezni volumen porazdelitve po subkutani aplikaciji je 11-17 l. Povprečni volumen porazdelitve po intravenski aplikaciji liraglutida je 0,07 l/kg.
English: Dose adjustments of griseofulvin and other compounds with low solubility and high permeability are not required.
Slovenian: Prilagoditev odmerka griseofulvina in drugih učinkovin z majhno topnostjo in veliko prepustnostjo ni potrebna.
English: Acute pancreatitis
Slovenian: Akutni pankreatitis
English: Figure 2: Forest plot of analyses of individual cardiovascular event types - FAS population
Slovenian: Slika 2: Drevesni diagram (»forest plot«) analize posameznih vrst srčno-žilnih dogodkovanaliza podatkov celotne populacije (FAS population)
English: If you have symptoms of acute pancreatitis, such as persistent, severe stomach ache, you should consult your doctor immediately (see section 4).
Slovenian: Če imate znake akutnega vnetja trebušne slinavke, na primer neprestane, hude bolečine v trebuhu, se takoj posvetujte z zdravnikom (glejte poglavje 4).
English: In particular, tell your doctor, pharmacist or nurse if you are using medicines containing any of the following active substances:
Slovenian: Še posebej pomembno pa je, da takoj obvestite zdravnika, farmacevta ali medicinsko sestro, če jemljete zdravila, ki vsebujejo katero koli od spodaj navedenih učinkovin:
English: Do not use this medicine after the expiry date which is stated on the pen label and carton after ‘EXP'.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki na injekcijskem peresniku in na škatli poleg oznake »Uporabno do« ali »EXP«.
English: Exposure was significantly lower (44%) in patients with severe hepatic impairment (Child Pugh score >9).
Slovenian: Izpostavljenost je bila bistveno nižja (44 %) pri bolnikih s hudo okvaro jeter (več kot 9 točk po Child
English: You may only split your dose between your current pen and a new pen if trained or advised by your healthcare professional.
Slovenian: Odmerek lahko razdelite med uporabljani peresnik in novi peresnik le, če ste za to usposobljeni oz. vam to svetuje vaš zdravnik.
English: Tell your doctor if you are, you think you might be, or are planning to become pregnant.
Slovenian: Nosečnost in dojenje Obvestite zdravnika, če ste noseči, mislite, da ste noseči, ali nameravate zanositi.
English: Antibody formation has not been associated with reduced efficacy of liraglutide.
Slovenian: Nastajanje protiteles ni bilo povezano z zmanjšanjem učinkovitosti liraglutida.
English: The efficacy and safety profile of Victoza was comparable to that observed in the adult population treated with Victoza.
Slovenian: Učinkovitost in varnostne značilnosti zdravila Victoza so bile primerljive tistim, ki so jih ugotovili v populaciji odraslih, zdravljenih z zdravilom Victoza.
English: * human glucagon-like peptide-1 (GLP-1) analogue produced by recombinant DNA technology in Saccharomyces cerevisiae.
Slovenian: * analog humanega glukagonu podobnega peptida-1 (GLP-1 - glucagon-like peptide-1), pridobljen s tehnologijo rekombinantne DNA iz Saccharomyces cerevisiae.
English: There was a comparable risk of hypoglycaemic episodes between the two treatment groups.
Slovenian: Tveganje za hipoglikemije je bilo med obema skupinama bolnikov primerljivo.
English: Victoza is available in packs containing 1, 2, 3, 5 or 10 pens.
Slovenian: Zdravilo Victoza je na voljo v pakiranjih z 1, 2, 3, 5 ali 10 injekcijskimi peresniki.
English: Always use a new needle for each injection.
Slovenian: Za vsako injiciranje vedno uporabite novo iglo.
English: In five large long-term clinical phase 3a trials over 2,500 adult patients have received treatment with Victoza alone or in combination with metformin, a sulfonylurea (with or without metformin) or metformin plus rosiglitazone.
Slovenian: V petih obsežnih in dolgotrajnih kliničnih preskušanjih faze 3a so več kot 2.500 odraslih bolnikov zdravili samo z zdravilom Victoza ali skupaj z metforminom, sulfonilsečnino (z ali brez metformina) ali metforminom in rosiglitazonom.
English: Unlike native GLP-1, liraglutide has a pharmacokinetic and pharmacodynamic profile in humans suitable for once daily administration.
Slovenian: Za razliko od naravnega GLP-1 ima liraglutid v človeškem telesu farmakokinetične in farmakodinamične lastnosti, ki omogočajo njegovo uporabo enkrat na dan.
English: Oral contraceptives
Slovenian: Peroralni kontraceptivi
English: The urine and faeces radioactivity was mainly excreted during the first 68 days, and corresponded to three minor metabolites, respectively.
Slovenian: Radioaktivnost v urinu in blatu se je v glavnem pojavila v prvih 6-8 dneh in je šla na račun treh manj pomembnih presnovkov.
English: If you forget a dose, use Victoza as soon as you remember.
Slovenian: Če ste pozabili uporabiti en odmerek, ga uporabite takoj, ko se spomnite.
English: In the LEADER trial, no long-term clinical impact of increased heart rate on the risk of cardiovascular events was observed.
Slovenian: LEADER niso opazili nobenega dolgotrajnega kliničnega vpliva povečanega srčnega utripa na tveganje za pojav srčno-žilnih dogodkov.
English: There was no clinically relevant effect on the overall exposure of either ethinyloestradiol or levonorgestrel.
Slovenian: Klinično pomembnega vpliva na celotno izpostavljenost etinilestradiolu ali levonorgestrelu ni bilo.
English: This medicine should not be used if you have type 1 diabetes (your body does not produce any insulin) or diabetic ketoacidosis (a complication of diabetes with high blood sugar and increase in effort to breathe).
Slovenian: Tega zdravila ne smete uporabljati, če imate sladkorno bolezen tipa 1 (vaše telo ne proizvaja insulina) ali diabetično ketoacidozo (zaplet sladkorne bolezni, kjer se pojavijo zelo visok krvni sladkor in težave pri dihanju).
English: Please see section 4 for the warning signs of low blood sugar.
Slovenian: Za opozorilne znake nizkega krvnega sladkorja glejte poglavje 4.
English: Consistent with the potentially immunogenic properties of medicinal products containing proteins or peptides, patients may develop anti-liraglutide antibodies following treatment with liraglutide.
Slovenian: Glede na morebitne imunogenske lastnosti zdravil, v katerih so beljakovine ali peptidi, se lahko po zdravljenju z liraglutidom pri bolnikih razvijejo protitelesa proti liraglutidu.
English: Signs and symptoms of dehydration, including renal impairment and acute renal failure, have been reported in patients treated with liraglutide.
Slovenian: Znaki in simptomi dehidracije, vključno z okvaro ledvic in akutno odpovedjo ledvic, so bili opisani pri bolnikih, ki se zdravijo z liraglutidom.
English: Caregivers must be very careful when handling used needles - to prevent needle injury and cross-infection.
Slovenian: Osebe, ki skrbijo za bolnika, morajo biti pri ravnanju z uporabljenimi iglami zelo pazljive, da preprečijo poškodbe z iglami in navzkrižno okužbo.
English: At the beginning of the therapy, these gastrointestinal adverse reactions may occur more frequently.
Slovenian: Na začetku zdravljenja so lahko ti neželeni učinki na prebavilih pogostejši.
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. PROIZVAJALEC BIOLOŠKE UČINKOVINE IN PROIZVAJALEC, ODGOVOREN ZA SPROŠČANJE SERIJ
English: Table 2 Liraglutide clinical phase 3 trials in monotherapy (52 weeks) and in combination with oral antidiabetics (26 weeks)
Slovenian: Preglednica 2 Monoterapija z liraglutidom v kliničnih preskušanjih 3. faze (52 tednov) in kombinirano zdravljenje s peroralnimi antidiabetiki (26 tednov)
English: Population pharmacokinetic analysis suggests that body mass index (BMI) has no significant effect on the pharmacokinetics of liraglutide.
Slovenian: Populacijska farmakokinetična analiza kaže, da indeks telesne mase (ITM) ne vpliva bistveno na farmakokinetiko liraglutida.
English: Overall, frequency, type and severity of adverse reactions in adolescents and children aged 10 years and above were comparable to that observed in the adult population.
Slovenian: Na splošno so bile pogostnost, vrsta in izrazitost neželenih učinkov pri mladostnikih in otrocih, starih 10 let ali več, podobne kot v odrasli populaciji.
English: Contents of the pack and other information What Victoza contains
Slovenian: Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Victoza
English: There is no therapeutic experience in patients with end-stage renal disease, and Victoza is therefore not recommended for use in these patients (see sections 5.1 and 5.2).
Slovenian: Terapevtskih izkušenj pri bolnikih z odpovedjo ledvic ni, zato uporaba zdravila Victoza pri teh bolnikih ni priporočljiva (glejte poglavji 5.1 in 5.2).
English: A clinically relevant interaction with active substances with poor solubility or with narrow therapeutic index such as warfarin cannot be excluded.
Slovenian: Klinično pomembnega medsebojnega delovanja liraglutida in učinkovin s slabo topnostjo in ozkim terapevtskim indeksom, kot je na primer varfarin, ni mogoče izključiti.
English: Tap the cartridge gently with your finger a few times.
Slovenian: S prstom nekajkrat rahlo potrkajte po vložku.
English: The risk of hypoglycaemia can be lowered by a reduction in the dose of sulfonylurea or insulin.
Slovenian: Tveganje za hipoglikemijo je mogoče zmanjšati z zmanjšanjem odmerka sulfonilsečnine ali insulina.
English: Combination with insulin
Slovenian: Kombinacija z insulinom
English: Do not stop using Victoza without talking to your doctor.
Slovenian: Ne prenehajte uporabljati zdravila Victoza, ne da bi se prej posvetovali z zdravnikom.
English: Victoza is supplied as a clear, and colourless or almost colourless, solution for injection in a pre-filled pen.
Slovenian: Zdravilo Victoza je na voljo kot bistra in brezbarvna ali skoraj brezbarvna raztopina za injiciranje v napolnjenem injekcijskem peresniku.
English: The absorption of liraglutide following subcutaneous administration is slow, reaching maximum concentration 8-12 hours post dosing.
Slovenian: Absorpcija liraglutida po subkutanem odmerku je počasna; največjo koncentracijo doseže v 8-12 urah po odmerku.
English: Five double-blind, randomised, controlled clinical phase 3a adult trials were conducted to evaluate the effects of liraglutide on glycaemic control (Table 2).
Slovenian: Opravljenih je bilo pet dvojno slepih, randomiziranih in kontroliranih kliničnih preskušanj faze 3a pri odraslih, v katerih so ocenjevali vpliv liraglutida na uravnavanje glikemije (preglednica 2).
English: • Wind (flatulence)
Slovenian: • vetrovi (napenjanje)
English: 26-week open label trial and were randomised to add liraglutide or a single dose of insulin aspart (with the largest meal).
Slovenian: Preostali bolniki so ostali v 26-tedenskem odprtem preskušanju in so bili randomizirani na dodatek liraglutida ali dodatek enega odmerka insulina aspart (ob največjem obroku).
English: • Bronchitis
Slovenian: • bronhitis
English: The treatment difference in HbA1c was 1.3% after additional 26 weeks of open label extension, confirming the sustained glycaemic control with Victoza.
Slovenian: Razlika v vrednosti HbA1c med zdravljenjema je bila po dodatnih 26 tednih odprtega podaljšanja 1,3 %; to potrjuje trajno urejenost glikemije z zdravilom Victoza.
English: Liraglutide reduced postprandial glucose across all three daily meals by 31-49 mg/dl (1.682.71 mmol/l).
Slovenian: Liraglutid je zmanjšal postprandialno koncentracijo glukoze po vseh treh dnevnih obrokih za 31-49 mg/dl (1,68-2,71 mmol/l).
English: You can keep the pen for 1 month when stored at a temperature below 30˚C or in a refrigerator (2˚C8˚C), away from the freezer compartment.
Slovenian: Injekcijski peresnik lahko shranjujete 1 mesec pri temperaturi do 30 °C ali v hladilniku (2 °C - 8 °C) ter proč od zamrzovalnega razdelka.
English: You may stick yourself with the needle.
Slovenian: Z iglo se lahko zbodete.
English: Victoza is used on its own if your blood sugar is not properly controlled by diet and exercise alone, and you cannot use metformin (another diabetes medicine).
Slovenian: Zdravilo Victoza se uporablja sámo, če krvni sladkor z dieto in s telesno vadbo ni zadostno urejen in ne morete jemati metformina (drugega zdravila za zdravljenje sladkorne bolezni).